|
HS Code |
488314 |
| Cas Number | 13988-27-7 |
| Molecular Formula | C10H13NO5 |
| Molecular Weight | 227.22 g/mol |
| Appearance | White to off-white solid |
| Melting Point | 78-82°C |
| Solubility | Soluble in common organic solvents (e.g., DCM, DMF) |
| Purity | Typically ≥98% |
| Storage Temperature | 2-8°C, protect from moisture |
| Synonyms | N-Succinimidyl cyclopentyloxycarbonyl carbonate |
| Iupac Name | 1-(2,5-dioxopyrrolidin-1-yl)oxycarbonylcyclopentane |
As an accredited N-(Cyclopentyloxycarbonyloxy)Succinimide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 25g N-(Cyclopentyloxycarbonyloxy)Succinimide is packaged in a sealed amber glass bottle with a tamper-evident screw cap. |
| Shipping | N-(Cyclopentyloxycarbonyloxy)Succinimide should be shipped in tightly sealed containers, protected from moisture, heat, and light. It is recommended to ship this chemical as a non-hazardous material via ground or air with appropriate labeling. Ensure compliance with local, national, and international regulations and include a safety data sheet (SDS) with the shipment. |
| Storage | N-(Cyclopentyloxycarbonyloxy)succinimide should be stored in a cool, dry, and well-ventilated area, away from moisture, heat, and direct sunlight. Keep the container tightly closed and store under an inert atmosphere, such as nitrogen or argon, to prevent hydrolysis and degradation. Avoid contact with oxidizing agents and acids. Properly label storage containers and follow all safety and handling regulations. |
Applications of N-(Cyclopentyloxycarbonyloxy)Succinimide in Industrial ManufacturingAs an original manufacturer of N-(Cyclopentyloxycarbonyloxy)succinimide, we supply consistent quality for integration across select high-value chemical sectors. Below, we detail specific downstream uses of our material in pharmaceutical, peptide synthesis, advanced research, and specialty chemical fields with technical process and compliance references. 1. Peptide Synthesis Reagent ManufacturingPeptide manufacturers employ this activated ester for the highly efficient coupling of protected amino acids during solid-phase synthesis. The cyclopentyloxycarbonyl group supports precise temporary protection, enabling selective deprotection steps and limiting racemization risk. Operators can achieve reproducible batch quality and maintain stringent reaction control, which is essential for early-stage peptide drug API development and high-purity research peptides. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Pharmaceutical Research Intermediate SynthesisMedicinal chemistry groups in pharmaceutical R&D utilize this compound for preparing specialty carbamate intermediates crucial to lead compound development. Its unique carbonyloxy leaving group facilitates the introduction of cyclopentyloxy moieties, enhancing metabolic stability and bioavailability profiles in small-molecule APIs. Fine-tuning the reaction is key for stable intermediate generation under regulated laboratory standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Custom Reagent Production for BioconjugationAnalytical chemistry suppliers use this activated ester for the targeted modification of proteins, oligonucleotides, and synthetic polymers. The reactivity profile allows site-specific labeling or conjugation without excess side reactions, which is critical for producing probes or affinity reagents used in life science instrumentation and clinical research applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Development of Enzyme Inhibitor LibrariesSpecialty chemical and contract research organizations synthesize focused inhibitor libraries using this compound for introducing constrained carbamate groups. The steric effect of the cyclopentyl ring supports design variations in covalent or pseudo-covalent enzyme blockers for screening purposes. Accurate structure control and purity monitoring are critical for credible assay data and patent submissions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive N-(Cyclopentyloxycarbonyloxy)Succinimide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing N-(Cyclopentyloxycarbonyloxy)succinimide takes a blend of practical chemistry knowledge and hands-on attention. From decades on the plant floor, I've seen countless reagents come and go. This compound, known colloquially in the lab as a reliable activated ester, delivers consistent performance. Inside the barrel or on the weighing scale, its off-white to pale yellow crystalline powder reveals strict process control from raw material selection through to final drying. The purity—frequently above 98% by HPLC on our lines—reflects careful purification, not just in theory but every day on site. We routinely check for related compounds using LC-MS and NMR, confirming the absence of persistent byproducts that plague lesser products.
Over the years, I have watched this compound become a top choice in peptide chemistry labs and industry peptide production lines. The reason for this shift is not just trends—it’s about practical utility. Cyclopentyloxycarbonyloxy is a highly effective leaving group. When paired with succinimide, the resulting product serves as a powerful coupling reagent, especially in solid-phase and solution-phase peptide synthesis. Chemists can achieve selective activation of carboxylic acids without excessive racemization.
Compared to other carbonyloxy-based N-hydroxysuccinimide reagents (like N-hydroxysuccinimide carbonate), this variant gives better control over reaction rates. I’ve personally seen reaction mixtures stay manageable longer, reducing pressure on the timeline and equipment. Peptide bonds form smoothly, leaving less room for side reactions. This means higher yields and fewer purification cycles downstream.
N-(Cyclopentyloxycarbonyloxy)succinimide appears as a stable, crystalline solid. Depending on process parameters, its melting point generally falls around 80–84°C. Our quality team verifies each batch with melting point and TLC comparison to reference standards, not just confirming identity but actual usability. Moisture content stays below 0.5% due to specialized vacuum drying, which preserves its activity until the moment the container is opened. Our technical sheets and batch-specific certificates rarely come back with deviation requests, since QC reflects actual GMP and ISO tasks, not just regulatory checkboxes.
In the lab, small portions dissolve rapidly in polar aprotic solvents—DMF and DCM get the most requests—forming a clear, homogeneous solution suited for stepwise reactions. Factory-scale syntheses benefit from its compatibility with large-batch vessels and pumps; we designed our own closed-loop feed lines to minimize exposure and keep operator safety at the core. Spills never turn gummy or produce hazardous vapors, so cleanup is straightforward.
A common way our customers use it is for introducing cyclopentyloxycarbonyl (CPOC) groups onto amino acids or peptides. This temporary protection shields amine groups, withstands a range of coupling conditions, then gets removed cleanly under mild acid. Over the years, feedback from medicinal chemistry teams tells us they like how rarely protecting groups fall off unexpectedly, which simplifies parallel synthesis. In process development, workers appreciate the ease of isolating intermediates with minimal chromatographic effort.
During my years developing and refining new esters, I’ve seen competitors tackle the active ester market with mixed results. Many push N-hydroxysuccinimide esters based only on familiar technology. But not every analog delivers the same efficiency or stability under variable warehouse conditions. For example, N-hydroxysuccinimide dicyclohexylcarbodiimide esters can offer even faster coupling, but at the cost of increased side reactions and tough-to-handle insoluble byproducts.
N-(Cyclopentyloxycarbonyloxy)succinimide sets itself apart with its unique balance between reactivity and shelf life. I’ve opened drums stored over a year in reasonable ambient conditions and found the product still punchy, evidence of real-world robustness. Our process eliminates excess starting materials, so sensitive residues don’t creep into subsequent steps. Chemists choosing between variants notice that the cyclopentyl ring, bulkier than ethyl or methyl, slows hydrolysis just enough to reduce wastage in humid climates.
This is where manufacturing experience counts. Standard esters may lose potency when shipped overseas or stored for long periods. Our customers in Brazil and India have commented on the difference after trying this compound—better integrity upon delivery, less clumping, and no unexpected color changes. Supply chain reliability always comes up in feedback: better supply comes from not cutting corners during synthesis, which is something no datasheet tells you.
Actual production relies heavily on batch control and strict environmental monitoring. I have spent mornings fussing over not just product handleability but also waste management. Our process captures volatile organic compounds through a two-stage scrubbing system. We recycle solvents tightly, both for cost savings and environmental stewardship. Since N-(Cyclopentyloxycarbonyloxy)succinimide involves relatively low-toxicity reagents, containment and emergency planning stay practical, with fewer surprises compared to older methods using more hazardous agents.
Our team tests each lot for residual solvents, metal contamination, and formal racemization studies. Small variations in process temperature have real impact on purity. We log every deviation, and any near-miss gets a root cause investigation right at the source, not shuffled into paperwork. Over years, this means we learned to avoid common production pitfalls, like over-aggressive drying that damages the product or too-long exposures that slowly reduce assay value.
I hear from peptide chemists and process engineers weekly about hurdles like batch-to-batch variability or inconsistent coupling efficacy from suppliers. As manufacturers, we see the entire chain from raw materials all the way to the packed product. Users ask for material that dissolves fully, gives clean product spots in HPLC, and stores well between uses. N-(Cyclopentyloxycarbonyloxy)succinimide excels in these goals due to its tailored synthesis route, not borrowed from another process but fine-tuned for this very product.
End users in pharma R&D and commercial scale have highlighted the need for on-demand support with detailed technical queries. Our lab staff, who work on synthesis scale-up and troubleshooting, aren’t separated from support calls or emails. We actually use the same material in pilot and preparative equipment as sold, so advice comes from experience, not from guessing off spec sheets. More than a few times, we’ve walked clients through solvent exchange or workup modifications that saved entire batches, and these adjustments feed directly into improving each new campaign.
It’s easy to talk about “green chemistry” in brochures. In reality, keeping waste down and emissions under control matters to both our team and local community. The route for N-(Cyclopentyloxycarbonyloxy)succinimide was chosen not by textbook but by hard-won testing for waste minimization. Total organic content in effluent stays low. We built solvent recovery straight into the workflow. Filtration steps recover trace product from washings, so material never goes into landfill or incinerator unless all value is recovered.
Handling unstable intermediates can risk exposure or accidental release, so we brought in improved ventilation at filter stations. I’ve spent extra shifts with the engineering team debugging a batch where filter paper broke down, leading to a near miss. Adaptations like switching to non-phenolic filter bodies make a real difference for health and compliance.
No innovation happens all at once. Decades of process tweaks and failures informed each successful drum shipped out the gate. Early on, we underestimated how a tweak in pH or solvent purity could throw off results. On one project, unexpected color formed after halfway storage, prompting a full investigation. We found that airtight drums and nitrogen blanketing did more than just protect the powder—they preserved every kilogram from humidity and oxidation.
Batch records aren’t checked off after the fact; live monitoring tells the truth in practice. Our senior chemists learned to keep a close eye on exothermic peaks and to introduce reagents at a controlled pace, so runaway reactions never spiral. Midway process sampling, not just at the endpoint, means fewer off-spec moments for our customers.
Active esters come in many forms. Some popular choices in the field, such as N-hydroxysuccinimide chloroformate or pentafluorophenyl esters, bring higher reactivity but also carry drawbacks in cost, storage, or hazardous byproducts. Over the years, we’ve run parallel syntheses comparing outcomes for clients seeking higher yield or easier workup. N-(Cyclopentyloxycarbonyloxy)succinimide balances reactivity, shelf life, and process safety.
Clients using older mixed carbonates often saw color instability and lower coupling efficiency after interim storage, leading to waste. More aggressive alternatives needed lower temperatures or more rigorous exclusion of water, raising cost and complexity. In contrast, our product can handle minor temperature fluctuations and routine air exposure with no obvious performance drop, eliminating last-minute surprises for process engineers.
For end-users, such as peptide or small-molecule manufacturers, the little differences count. Time spent purifying or debugging batches costs real money and misses deadlines. Minimizing formation of side products shortens both reaction and cleanup time, allowing chemists to focus on development instead of fixing problems. Feedback from multiple sites—big and small, in North America, Europe, Asia—points to smoother scale-up and comfortable handling over cycles ranging from gram lab batches to tens of kilograms in single campaigns.
Having worked on both the production and user end, I know many challenges only show up during actual process execution. Our team doesn’t just take notes; we try out adjustments ourselves before recommending them. For example, when a partner struggled with solubility during scale-up, we tested alternative solvent blends in our own reactors, logging exact yields and tracking impurity trends. Final advice was based on concrete data, not speculative theory.
Sometimes advice travels both ways—end-users report faster bond formation with specific base combinations, so we run pilot tests to see if the effect holds up across batches. If it does, production is adjusted to optimize for the best performance for those applications. This feedback loop is built on actual conversations and detailed process knowledge. As a result, improvements roll out incrementally, without forcing users to keep relearning new procedures.
Current expectations in chemical manufacturing go beyond supply availability—they’re about predictability and accountability. Regular audits from pharmaceutical clients mean our site stays ready for visits, with all records up to date. Material traceability extends from the lot drum back to every raw chemical received. We’ve had teams from three continents visit for live production tours, observing the workflow and even swabbing surfaces for contamination testing.
Emergency response and contamination control never fade from top priorities. The process flow has built-in redundancies: backup power for cooling, secondary containment for every high-volume reagent, and vent scrubbers constantly monitored, not just during regulatory windows. These methods often catch minor issues before bigger operational problems build. What results is a product with not just technical credentials but a proven reliability, batch after batch.
Quality control means actual chemical tests, not just paperwork. Our plant’s analytical chemists take pride in confirming purity by multiple orthogonal techniques. Every batch runs through TLC, HPLC, NMR, and moisture analysis. More than once, teams have caught edge-case impurities only visible on specific detectors. No batch leaves without direct, hands-on sign-off from someone who spent time in both production and development.
For users worried about batch-to-batch differences, real assurance comes from an unobstructed production path. We produce every kilogram in the same facility, using reactors and filtration optimized for this product—never shared with incompatible intermediates that could introduce unpredictability. For every customer, big or small, the material in each drum shows the same lot-specific consistency.
Many of today's customers source globally, so stable supply and assured stability matter all the more. Unexpected delays or transit hiccups challenge even the best-laid plans. We ship N-(Cyclopentyloxycarbonyloxy)succinimide in double-lined, moisture-barrier containers tested against tropical environments. Developed after actual incidents in Southeast Asia, these containers make a real difference to product preservation.
Shipping stability impacts downstream use. I recall batches shipped in rainy seasons that survived unscathed, verifying both in-house climate chamber trials and real delivery routes. Large buyers keep backup stock, but smaller teams often rely on single-delivery timing. Feedback cycles like these drive continuous improvement in packaging and documentation.
Production methods never stand still. Just as market requests shift, so does our manufacturing. We track new synthesis routes in academic literature and pilot those with promise in our R&D labs—not because it reads well, but because even a five percent reduction in byproduct can mean thousands in savings over the year. Our technical staff, having produced this compound at ton scale, never assumes today’s process is the endpoint. Process engineers and synthetic chemists adjust parameters, test alternative acids, or trial new solvents not out of curiosity, but because each improvement carries over to every partner’s bottom line.
Open lines between us and users drive much of this innovation. Early notification of technical trouble, or even potential supply disruptions, gets rapid response. Technical advances, such as flow chemistry or sealed reactors, are piloted for this product as soon as viability can be proven at bench scale. We maintain open records with trusted collaborators, so genuine advances are adopted rapidly. In practice, customers get a product that’s informed by community use, not locked in a time capsule.
After working hands-on for years, I value products that earn trust not just in single reactions but across entire campaigns. N-(Cyclopentyloxycarbonyloxy)succinimide’s reliable reactivity, shelf stability, and practical safety profile make it indispensable in both R&D and industrial settings. What sets it apart is not just technical superiority or cost. It’s the real-life impact on every stage—from seamless handling in the factory to minimized waste at bench and scale, all supported by people who answer technical questions with lived experience.
Whether handling multi-kilogram synthesis or prepping key intermediates for drug candidates, the product serves not just as another item on a list but as a mainstay in practical organic chemistry. The value comes from dependable interaction between users and manufacturers, translating chemical know-how into actual solutions in countless labs worldwide.